Blood substitute trauma study to continue without change
This article was originally published in Clinica
Executive Summary
Northfield Laboratories is pressing on with a pivotal phase III clinical investigation of its blood substitute PolyHeme in trauma patients, after the first independent review of the study's safety showed that it could continue without modification.